Stem cell sponsor sees veto-proof Senate backing (Reuters)


Reuters - An expansion of federally funded
embryonic stem cell research could pass the U.S. Senate with a
veto-proof margin now that the chamber's leader backs the idea,
a leading sponsor of the effort said on Sunday.

Read more...